Establishing DNA Damage Response-Deficient (DDRD) Status in Patients with Advanced Oesophageal Adenocarcinoma who have had an Exceptional Response to First Line Chemotherapy

StatusFinished
Effective start/end date1/03/1931/08/19

Funding

  • (T18-20): £20,000.00